Phreesia, Inc. (PHR) Research

Phreesia, Inc. offers a comprehensive, cloud-based software-as-a-service (SaaS) and payment platform specifically designed for the healthcare industry in the United States and Canada. Its flagship Phreesia Platform streamlines the patient intake process and facilitates integrated patient payment processing. The platform is accessible via multiple modalities, including Phreesia Mobile (a patient-facing mobile application), Phreesia Dashboard (a web-based portal for healthcare clients), self-service tablets known as PhreesiaPads, and on-site Arrivals Kiosks. The Phreesia Platform integrates a suite of specialized modules: An automated patient self-registration system. A revenue cycle management solution providing insurance verification, point-of-sale payment applications, and cost estimation tools. Access solutions for online appointment scheduling, reminders, and referral tracking. A life sciences solution delivering targeted, clinically relevant marketing content to patients. Additionally, a clinical support solution gathers clinical intake and patient-reported outcome (PRO) data across approximately 25 specialties, and enables healthcare clients to communicate with patients via surveys, announcements, text and email messaging, and health campaigns. Dedicated COVID-19 support modules assist with vaccine delivery management, identifying vaccine-hesitant individuals, screening for risk factors, facilitating contactless check-in, and managing telehealth visit intake. Phreesia serves a diverse clientele, including individual patients; single and multi-specialty practices, along with health systems; and pharmaceutical, medical device, and biotechnology firms. Established in 2005, the company maintains its headquarters in Raleigh, North Carolina.

Market snapshot

Symbol
PHR
Price
$9.38
Day change
+0.32%
Market cap
$579.8M
P/E ratio
62.25x
52-week range
7.77-32.76
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Next earnings
in 3 months
Analyst price target
$13.57

Peer companies

  • BioLife Solutions, Inc. (BLFS)
  • Establishment Labs Holdings Inc. (ESTA)
  • GoodRx Holdings, Inc. (GDRX)
  • Kestra Medical Technologies, Ltd. (KMTS)
  • Neogen Corporation (NEOG)
  • NovoCure Limited (NVCR)
  • Omnicell, Inc. (OMCL)
  • Omada Health (OMDA)

Recent insider activity

  • Hui Yvonne — S-Sale (431 shares) on 2026-05-18
  • Hui Yvonne — F-InKind (325 shares) on 2026-05-18
  • CAHILL EDWARD L — A-Award (1085 shares) on 2026-04-30
  • Goldstein Lainie — A-Award (1085 shares) on 2026-04-30
  • Munson Gillian — A-Award (1085 shares) on 2026-04-30

Open Phreesia, Inc. (PHR) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.